prikaz prve stranice dokumenta Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry
Access restricted to all Croatian higher education institution's students and staff
Scientific paper - Letter
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry
Haematologica, 109 (2024), 8; 2693-2700. https://doi.org/10.3324/haematol.2023.284678
(EPICOVIDEHA) Aiello, TF; Salmanton-Garcia, J; ...; ...; Valković, Toni; ...; ...

Institutional repository: Repository of the University of Rijeka, Faculty of Medicine

Cite this document

Aiello, T., Salmanton Garcia, J. & Valković, T. (2024). Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry. Haematologica, 109. (8), 2693-2700. doi: 10.3324/haematol.2023.284678

Aiello, TF, et al. "Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry." Haematologica, vol. 109, no. 8, 2024, pp. 2693-2700. https://doi.org/10.3324/haematol.2023.284678

Aiello, TF, J Salmanton Garcia and Toni Valković. "Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry." Haematologica 109, no. 8 (2024): 2693-2700. https://doi.org/10.3324/haematol.2023.284678

Aiello, T., Salmanton Garcia, J. and Valković, T. (2024) 'Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry', Haematologica, 109(8), pp. 2693-2700. doi: 10.3324/haematol.2023.284678

Aiello T, Salmanton Garcia J, Valković T. Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry. Haematologica [Internet]. 2024 April 04 [cited 2024 December 24];109(8):2693-2700. doi: 10.3324/haematol.2023.284678

T. Aiello, J. Salmanton Garcia and T. Valković, "Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry", Haematologica, vol. 109, no. 8, pp. 2693-2700, April 2024. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:437967. [Accessed: 24 December 2024]

Metadata
Title (english)Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry
AuthorTF Aiello
AuthorJ Salmanton-Garcia
Author
...
Author
...
AuthorToni Valković
Author
...
Author
...
CollaborationEPICOVIDEHA
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Languageenglish
Publication typeScientific paper - Letter
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Journal titleHaematologica
Numberingvol. 109, no. 8, pp. 2693-2700
p-ISSN0390-6078
e-ISSN1592-8721
DOIhttps://doi.org/10.3324/haematol.2023.284678
URN:NBNurn:nbn:hr:184:437967
Publication2024-04-04
Document URLhttps://haematologica.org/article/view/haematol.2023.284678
Type of resourceText
Access conditionsRestricted access
Terms of useLicence In copyright icon
Created on2024-08-23 08:39:42